How to Expand Your Pharmaceutical Portfolio in Latin America Through Strategic Licensing
Pharmaceutical licensing allows companies to access innovative or differentiated generic products without the need for in-house development. Through strategic agreements, a company can obtain commercialization rights within its territory, optimizing both time and resources.
🌎 Why is Latin America a major opportunity?
Latin America is a high-growth region driven by:
- Increasing prevalence of chronic diseases such as diabetes and cancer
- Evolving regulatory systems
- Strong demand for specialized therapies
- Open market opportunities for differentiated products
Countries such as Mexico, Colombia, Peru, and Central America are actively seeking to expand their portfolios with innovative, value-added products.
💊 Therapeutic areas with the highest potential
To maximize commercial impact, it is essential to focus on high-demand therapeutic areas:
- Oncology: targeted therapies and innovative molecules such as enzalutamide, apalutamide, olaparib, and venetoclax
- Central Nervous System (CNS): treatments for epilepsy, depression, and neurodegenerative diseases such as lumateperone, cariprazine, and clomipramine
- Diabetes and metabolism: new combinations and clinically valuable molecules such as insulin glargine, insulin aspart, insulin degludec, and injectable semaglutide
- Gastroenterology: treatments for chronic digestive diseases such as vonoprazan and tegoprazan
- Men’s health: therapies for erectile dysfunction, prostate conditions, and urinary tract issues such as methenamine hippurate, mirabegron XR, and mirabegron + solifenacin
- Supplements: rapid growth of the OTC and wellness market
⚠️ Common challenges in licensing
Despite its benefits, many companies face challenges such as:
- Identifying reliable partners
- Technical and regulatory dossier evaluation
- Negotiating commercial terms
- Adapting to local regulatory requirements (INVIMA, COFEPRIS, DIGEMID, ANMAT, etc.)
🤝 How can INPHORIA support you?
At INPHORIA, we act as a strategic partner in pharmaceutical licensing for Latin America, connecting companies with real business opportunities.
Our services include:
- Identifying products aligned with your strategy
- Dossier evaluation and regulatory feasibility assessment
- Sourcing international partners (India, Europe, Asia)
- Deal negotiation
- End-to-end support through regulatory approval and post-launch commercialization
📈 Conclusion
Pharmaceutical licensing is one of the most efficient ways to expand your portfolio in LATAM. With the right partner, you can reduce risk, accelerate time-to-market, and gain access to high-value products.
👉 Looking to expand your portfolio in Latin America?
At INPHORIA, we help you identify the best opportunities for your business.
